Yu Shen

17.3k total citations
292 papers, 8.8k citations indexed

About

Yu Shen is a scholar working on Oncology, Cancer Research and Statistics and Probability. According to data from OpenAlex, Yu Shen has authored 292 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 81 papers in Cancer Research and 59 papers in Statistics and Probability. Recurrent topics in Yu Shen's work include Breast Cancer Treatment Studies (58 papers), Statistical Methods and Inference (42 papers) and Global Cancer Incidence and Screening (31 papers). Yu Shen is often cited by papers focused on Breast Cancer Treatment Studies (58 papers), Statistical Methods and Inference (42 papers) and Global Cancer Incidence and Screening (31 papers). Yu Shen collaborates with scholars based in United States, China and Spain. Yu Shen's co-authors include Jing Qin, Sijin Wen, Randall E. Millikan, Arlene O. Siefker‐Radtke, Jing Ning, Colin P. Dinney, Isabelle Bedrosian, Stephen W. Fesik, Elihu H. Estey and Louis L. Pisters and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Shen

277 papers receiving 8.6k citations

Peers

Countries citing papers authored by Yu Shen

Since Specialization

Citations

This map shows the geographic impact of Yu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Shen more than expected).

Fields of papers citing papers by Yu Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Shen. The network helps show where Yu Shen may publish in the future.

Co-authorship network of co-authors of Yu Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Shen. A scholar is included among the top collaborators of Yu Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Shen. Yu Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modeling 2025 ·Scientific Reports ·Wenli Dong, Takeo Fujii, Jing Ning, Toshiaki Iwase, Jing Qin, Naoto T. Ueno, Yu Shen	2
2	Dual‐Selection Strategy for Generating Knock‐Out Lines of Human Embryonic Stem Cells 2025 ·Journal of Cellular and Molecular Medicine ·Ziyu Zhou, (unknown), (unknown), (unknown), Yu Shen, (unknown)	0
3	Effects of exercise during pregnancy on maternal and newborn outcomes 2025 ·BMC Pregnancy and Childbirth ·Yu Shen, Yi Wang, Peng Huang	0
4	A Stackelberg game for optimal control energy of multi-agent networks under cyber-attacks 2025 ·International Journal of Control ·Shiyang Xu, Yongqiang Guan, Yu Shen	0
5	Alumni network, mutual fund herding and information spillover: Evidence from China 2024 ·Pacific-Basin Finance Journal ·Yu Shen, (unknown), Yaxuan Liu	1
6	Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework 2024 ·JNCI Journal of the National Cancer Institute ·(unknown), Jiangong Niu, Martin C. Tammemägi, Ehsan Irajizad, Yu Shen, Karen H. Lu, Larissa A. Meyer, Iakovos Toumazis	4
7	243MO Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial 2023 ·Annals of Oncology ·Henry M. Kuerer, Gaiane M. Rauch, Savitri Krishnamurthy, Emilia J. Diego, Wei Yang, Yu Shen, Heather Lin, Anthony Lucci, Timothy A. Moseley, (unknown), Jason Mouabbi, Judy C. Boughey, Simona F. Shaitelman, Richard L. White, Kelly K. Hunt, Melissa P. Mitchell, Mediget Teshome, Helen M. Johnson, Benjamin D. Smith, Vicente Valero	1
8	Accommodating Time-Varying Heterogeneity in Risk Estimation under the Cox Model: A Transfer Learning Approach 2023 ·Journal of the American Statistical Association ·Ziyi Li, Yu Shen, Jing Ning	7
9	Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis 2021 ·npj Breast Cancer ·David Boyce-Fappiano, Isabelle Bedrosian, Yu Shen, Heather Lin, Olsi Gjyshi, (unknown), Simona F. Shaitelman, Wendy A. Woodward	12
10	Modeling the Coronavirus Disease 2019 Incubation Period: Impact on Quarantine Policy 2020 ·Mathematics ·Daewoo Pak, Klaus Langohr, Jing Ning, Jordi Cortés, Guadalupe Gómez Melis, Yu Shen	9
11	Acquired Resistance to BET-PROTACs (Proteolysis-Targeting Chimeras) Caused by Genomic Alterations in Core Components of E3 Ligase Complexes 2019 ·Molecular Cancer Therapeutics ·Lu Zhang, Bridget Riley‐Gillis, Priyanka Vijay, Yu Shen	231
12	Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes 2019 ·Breast Cancer Research and Treatment ·Anna Weiss, Heather Lin, Gildy V. Babiera, Isabelle Bedrosian, Simona F. Shaitelman, Yu Shen, Henry M. Kuerer, Elizabeth A. Mittendorf, Abigail S. Caudle, Kelly K. Hunt, Rosa F. Hwang	21
13	Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors 2017 ·Molecular Cancer Therapeutics ·Lloyd T. Lam, Xiaoyu Lin, Emily J. Faivre, Ziping Yang, Xiaoli Huang, Denise M. Wilcox, Richard J. Bellin, Sha Jin, Stephen K. Tahir, Michael J. Mitten, (unknown), Anahita Bhathena, Warren M. Kati, Daniel H. Albert, Yu Shen, Tamar Uziel	55
14	Estimating treatment effects in observational studies with both prevalent and incident cohorts 2017 ·Canadian Journal of Statistics ·Jing Ning, Chuan Hong, Liang Li, Xuelin Huang, Yu Shen	7
15	Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075 2016 ·Molecular Cancer Research ·Emily J. Faivre, Denise Wilcox, Xia Li, Paul Hessler, Maricel Torrent, Wei He, Tamar Uziel, Daniel H. Albert, Keith F. McDaniel, Warren M. Kati, Yu Shen	53
16	HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues 2016 ·Molecular Cancer Therapeutics ·Xiaoyu Lin, Xiaoli Huang, Tamar Uziel, Paul Hessler, Daniel H. Albert, Lisa Roberts-Rapp, Keith F. McDaniel, Warren M. Kati, Yu Shen	45
17	Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy 2013 ·Cancer Immunology Research ·Derek Ng Tang, Yu Shen, Jingjing Sun, Sijin Wen, Jedd D. Wolchok, Jianda Yuan, James P. Allison, Padmanee Sharma	146
18	The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo 2011 ·Molecular Cancer Therapeutics ·Jun Chen, Sha Jin, (unknown), Xiaoli Huang, Bernard A. Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey L. Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel Johansson, Chris Tse, Steven W. Elmore	119
19	A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation 2008 ·Proceedings of the National Academy of Sciences ·Xia Li, (unknown), (unknown), (unknown), Navdeep S. Chandel, Xiaoli Huang, Usha Warrior, Frank Weinberg, Kathryn V. Tormos, Stephen W. Fesik, Yu Shen	85
20	Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma 2006 ·Clinical Cancer Research ·Padmanee Sharma, Yu Shen, Sijin Wen, Dean F. Bajorin, Victor E. Reuter, Lloyd J. Old, Achim A. Jungbluth	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact